320 filings
Page 4 of 16
8-K
bwa62 c1ii
1 Dec 22
NanoVibronix Announces $2.4 Million Registered
6:06am
424B5
v3edtl bdunjyy1gtl
30 Nov 22
Prospectus supplement for primary offering
5:29pm
8-K
c84fkxmn6z x1613
29 Nov 22
NanoVibronix Receives FDA 510(k) Premarket Clearance for PainShield Plus
9:13am
8-K
91rx0f7og io
16 Nov 22
NanoVibronix Announces Interim Results of Clinical Study for UroShield
8:30am
DEFA14A
8aaq7hb
15 Nov 22
Additional proxy soliciting materials
9:26am
DEFA14A
4i3r bv3lmw6g
31 Oct 22
Additional proxy soliciting materials
8:20am
8-K
m5i624ut
19 Oct 22
NanoVibronix Receives Extension to Satisfy Nasdaq Price Requirement
8:30am
8-K
6xxm9u5khs1y3
23 Sep 22
NanoVibronix UroShield Approved for Sale through NHS Internal
8:30am
DEFA14A
mprgzp
15 Sep 22
Additional proxy soliciting materials
9:40am
8-K
1qmq idvnowkqf
15 Sep 22
Nanovibronix Sets Date for Annual Shareholder Meeting
9:30am
8-K
hws1vs8
14 Sep 22
NanoVibronix Announces Distribution of Series F Preferred Stock to Holders of its Common Stock
10:21am
8-A12G
e5ogvv6cn
14 Sep 22
Registration of securities
9:46am
DEFA14A
s1cn 6lvkzfojfis5
2 Sep 22
Additional proxy soliciting materials
4:31pm
8-K
r19vxjio
2 Sep 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
536fo hslf9nbk7nasng
2 Sep 22
Other Events
4:30pm
DEFA14A
1d8q cwwbi2pz0dvvt8
26 Jul 22
Additional proxy soliciting materials
4:10pm